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Abstract
A simulation model to predict the survival probability of individual patients with hepato-
cellular carcinoma (HCC) after therapy was derived from the results of various therapies and
follow-up studies of 450 HCC patients. Twenty-two prognostically important variables were
analyzed by Cox’s proportional hazards model. The 9 significant variables that were extracted
were used to build the simulation. In this model, S(t), the expected estimated survival rate
for individual patient at time t (month), is calculated by the following equation: S(t) = (exp (-
0.03655t) (exp [0.9479 ([portal vein invasion]-0.222) + 0.3846 ([tumor number]-2.00) + 0.2578
([tumor size]-3.231) + 0.0742 ([loge AFP]-5.647) + 0.8184 ([metastasis]-0.036) + 0.2810 ([Child’s
class]-1.689)-0.7088 ([transcatheter arterial embolization]-0.578)-0.9746 ([percutaneous ethanol
injection]-0.153)-0.5377 ([hepatectomy]-0.109)]) The validity of the model was assessed using a
split-sample technique. This paper does not discuss the superiority or inferiority of the therapies,
because some selection bias for prognostic factors among the therapies can not be completely ex-
cluded. But this model is proposed as a practical model to predict the survival of patients with
HCC.
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